Product Images Fluzone Trivalent Northern Hemisphere
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Fluzone Trivalent Northern Hemisphere NDC 49281-425 by Sanofi Pasteur Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 5 mL Vial Label - fluzonemdv 01
This is information about a 5 mL multi-dose vial of Influenza Vaccine called Fluzone®. It is indicated for individuals aged 6 months and older. The vaccine contains a preservative and should not be frozen, but stored between 2°C to 8°C (35°F to 46°F). The vial contains 5 mL of the vaccine and can be administered in doses of 0.25 mL or 0.5 mL for individuals aged 6 to 35 months and 0.5 mL for those 3 years and older. It is for intramuscular use, and the package insert should be referred to for detailed administration instructions. The vaccine is manufactured by Sanofi Pasteur Inc. and has a US Government License number #1725.*
PRINCIPAL DISPLAY PANEL - 5 mL Vial Package - fluzonemdv 02
This is a description of an influenza vaccine called Fluzone® intended for individuals 6 months of age and older. It is meant for intramuscular use and comes in a 5 mL multi-dose vial. The vaccine is designed for the 2023-2024 influenza season and contains specific strains of the flu virus. It is advised not to freeze the vaccine and to store it between 2°C to 8°C (35°F to 46°F). The vaccine is standardized according to USPHS requirements and is formulated to contain hemagglutinin representative of specific influenza virus strains.*
PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label - fluzonepfs 03
This is a description of an Influenza Vaccine called Fluzone intended for Intramuscular use. It is a single-dose product without preservatives, manufactured by Sanofi Pasteur Inc. The 2023-2024 formula is indicated and it comes in 0.5 mL volume. The National Drug Code (NDC) for this product is 49281-312-88.*
PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Package - fluzonepfs 04
This text provides details about the Fluzone Reony Influenza Vaccine, suitable for intramuscular use for individuals 6 months of age and older. The vaccine is presented in 10 single-dose prefilled syringes, each containing 0.5 mL. It should be stored between 2°C to 8°C and should not be frozen. The vaccine is formulated to contain 45 micrograms hemagglutinin per 0.5 mL dose and is standardized according to USPHS requirements for the 2023-2024 influenza season. The text also mentions the specific prototype strains included in the vaccine and indicates that it contains no preservatives or natural rubber latex. The manufacturing information and trademark details are also provided within the text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
